1 |
TNFSF13B
| 3件: NF-kappa B signaling pathway NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis | D03068
D03068
|
Belimumab
| 13件: 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 |
2 |
TNFSF13B
| 3件: NF-kappa B signaling pathway NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis | D09704
D09704
|
Atacicept
| 4件: 13 13, 46, 49, 66 |
3 |
TNFSF13B
| 3件: NF-kappa B signaling pathway NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis | D10083
D10083
|
Tabalumab
| 2件: 46 46, 49 |
4 |
TNFSF13B
| 3件: NF-kappa B signaling pathway NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis | D11127
D11127
|
Tibulizumab
| 1件: 53 53 |
5 |
TNFRSF13C
| 3件: NF-kappa B signaling pathway NF-kappa B signaling pathway, Intestinal immune network for IgA production, Primary immunodeficiency | D12151
D12151
|
Ianalumab
| 7件: 35 35, 46, 49, 53, 61, 63, 95 |
6 |
IL4
| 8件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Intestinal immune network for IgA production, Leishmaniasis, Pathways in cancer | D03117
D03117
|
Binetrakin
| 1件: 46 46 |
7 |
IL5
| 5件: JAK-STAT signaling pathway JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, T cell receptor signaling pathway, Intestinal immune network for IgA production, Pathways in cancer | D04923
D04923
|
Mepolizumab
| 4件: 44 44, 45, 98, 162 |
8 |
IL5
| 5件: JAK-STAT signaling pathway JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, T cell receptor signaling pathway, Intestinal immune network for IgA production, Pathways in cancer | D08985
D08985
|
Reslizumab
| 2件: 44 44, 98 |
9 |
IL6
| 24件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, TNF signaling pathway, Intestinal immune network for IgA production, Non-alcoholic fatty liver disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Malaria, Tuberculosis, Measles, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Transcriptional misregulation in cancer, Rheumatoid arthritis, Lipid and atherosclerosis | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
10 |
IL6
| 24件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, TNF signaling pathway, Intestinal immune network for IgA production, Non-alcoholic fatty liver disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Malaria, Tuberculosis, Measles, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Transcriptional misregulation in cancer, Rheumatoid arthritis, Lipid and atherosclerosis | D08976
D08976
|
Pomalidomide
| 5件: 28 28, 51, 85, 227, 331 |
11 |
IL6
| 24件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, TNF signaling pathway, Intestinal immune network for IgA production, Non-alcoholic fatty liver disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Malaria, Tuberculosis, Measles, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Transcriptional misregulation in cancer, Rheumatoid arthritis, Lipid and atherosclerosis | D09669
D09669
|
Siltuximab
| 2件: 28 28, 331 |
12 |
IL6
| 24件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, TNF signaling pathway, Intestinal immune network for IgA production, Non-alcoholic fatty liver disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Malaria, Tuberculosis, Measles, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Transcriptional misregulation in cancer, Rheumatoid arthritis, Lipid and atherosclerosis | D10080
D10080
|
Sirukumab
| 2件: 41 41, 46 |
13 |
IL6
| 24件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th17 cell differentiation, TNF signaling pathway, Intestinal immune network for IgA production, Non-alcoholic fatty liver disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Malaria, Tuberculosis, Measles, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Transcriptional misregulation in cancer, Rheumatoid arthritis, Lipid and atherosclerosis | D12487
D12487
|
Olokizumab
| 2件: 46 46, 96 |
14 |
IL10
| 12件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, JAK-STAT signaling pathway, T cell receptor signaling pathway, Intestinal immune network for IgA production, Pertussis, Yersinia infection, Leishmaniasis, Malaria, Toxoplasmosis, Staphylococcus aureus infection, Tuberculosis, Systemic lupus erythematosus | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
15 |
ITGA4
| 6件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Yersinia infection, Leishmaniasis | D06590
D06590
|
Firategrast
| 1件: 13 13 |
16 |
ITGA4
| 6件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Yersinia infection, Leishmaniasis | D06886
D06886
|
Natalizumab
| 6件: 13 13, 15, 25, 46, 63, 96 |
17 |
ITGA4
| 6件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Yersinia infection, Leishmaniasis | D08083
D08083
|
Vedolizumab
| 3件: 94 94, 96, 97 |
18 |
ITGA4
| 6件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Yersinia infection, Leishmaniasis | D10540
D10540
|
Abrilumab
| 2件: 96 96, 97 |
19 |
ITGB7
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer | D08083
D08083
|
Vedolizumab
| 3件: 94 94, 96, 97 |
20 |
ITGB7
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer | D09901
D09901
|
Etrolizumab
| 2件: 96 96, 97 |
21 |
ITGB7
| 4件: PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer | D10540
D10540
|
Abrilumab
| 2件: 96 96, 97 |
22 |
TNFRSF17
| 1件: Intestinal immune network for IgA production Intestinal immune network for IgA production | D11595
D11595
|
Belantamab mafodotin
| 1件: 28 28 |
23 |
TGFB1
| 16件: MAPK signaling pathway MAPK signaling pathway, TGF-beta signaling pathway, Osteoclast differentiation, Th17 cell differentiation, Intestinal immune network for IgA production, Relaxin signaling pathway, Non-alcoholic fatty liver disease, Leishmaniasis, Malaria, Toxoplasmosis, Tuberculosis, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Pancreatic cancer, Rheumatoid arthritis | D09620
D09620
|
Fresolimumab
| 3件: 51 51, 85, 222 |
24 |
CXCR4
| 7件: Viral life cycle - HIV-1 Viral life cycle - HIV-1, Virion - Human immunodeficiency virus, Viral protein interaction with cytokine and cytokine receptor, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Pathways in cancer | D08971
D08971
|
Plerixafor
| 5件: 19 19, 20, 65, 285, 299 |
25 |
TNFSF13
| 2件: Intestinal immune network for IgA production Intestinal immune network for IgA production, Rheumatoid arthritis | D09704
D09704
|
Atacicept
| 4件: 13 13, 46, 49, 66 |
26 |
CD80
| 7件: Virion - Adenovirus Virion - Adenovirus, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Systemic lupus erythematosus, Rheumatoid arthritis, Viral myocarditis | D03203
D03203
|
Abatacept
| 26件: 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 |
27 |
CD80
| 7件: Virion - Adenovirus Virion - Adenovirus, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Systemic lupus erythematosus, Rheumatoid arthritis, Viral myocarditis | D03222
D03222
|
Belatacept
| 1件: 46 46 |
28 |
CD86
| 9件: Virion - Adenovirus Virion - Adenovirus, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Kaposi sarcoma-associated herpesvirus infection, Transcriptional misregulation in cancer, Systemic lupus erythematosus, Rheumatoid arthritis, Viral myocarditis | D03203
D03203
|
Abatacept
| 26件: 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 |
29 |
CD86
| 9件: Virion - Adenovirus Virion - Adenovirus, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Kaposi sarcoma-associated herpesvirus infection, Transcriptional misregulation in cancer, Systemic lupus erythematosus, Rheumatoid arthritis, Viral myocarditis | D03222
D03222
|
Belatacept
| 1件: 46 46 |
30 |
CD40
| 10件: NF-kappa B signaling pathway NF-kappa B signaling pathway, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Malaria, Toxoplasmosis, Transcriptional misregulation in cancer, Systemic lupus erythematosus, Primary immunodeficiency, Viral myocarditis, Lipid and atherosclerosis | D11357
D11357
|
Bleselumab
| 1件: 222 222 |
31 |
CD40
| 10件: NF-kappa B signaling pathway NF-kappa B signaling pathway, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Malaria, Toxoplasmosis, Transcriptional misregulation in cancer, Systemic lupus erythematosus, Primary immunodeficiency, Viral myocarditis, Lipid and atherosclerosis | D11597
D11597
|
Ravagalimab
| 2件: 53 53, 97 |
32 |
CD40
| 10件: NF-kappa B signaling pathway NF-kappa B signaling pathway, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Malaria, Toxoplasmosis, Transcriptional misregulation in cancer, Systemic lupus erythematosus, Primary immunodeficiency, Viral myocarditis, Lipid and atherosclerosis | D11610
D11610
|
Iscalimab
| 2件: 49 49, 53 |
33 |
CD40LG
| 9件: NF-kappa B signaling pathway NF-kappa B signaling pathway, T cell receptor signaling pathway, Intestinal immune network for IgA production, Malaria, Toxoplasmosis, Systemic lupus erythematosus, Primary immunodeficiency, Viral myocarditis, Lipid and atherosclerosis | D06193
D06193
|
Toralizumab
| 1件: 63 63 |